The use of two NADPH oxidase inhibitors, apocynin and diphenyleneiodonium chloride, decreases the formation of NETs in high-glucose neutrophils and in patients with diabetes: the formation induced by high glucose is dependent on NADPH oxidase [73]. Here, FMO5 is linked to diabetes mellitus.